In vitro experiments have shown HER2 CAR-T cells can successfully kill glioma cells [25], but more in depth in vivo studies need to be conducted as HER2 is expressed on normal tissues as well [26]. This evidence concerns the gene ERBB2 and central nervous system cancer.